|
SCP2 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.155900E-03 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.779200E-03 |
| Normal-vs-AfricanAmerican |
1.524480E-02 |
| Normal-vs-Asian |
1.449790E-01 |
| Caucasian-vs-AfricanAmerican |
1.821580E-01 |
| Caucasian-vs-Asian |
8.519400E-01 |
| AfricanAmerican-vs-Asian |
6.389800E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.415800E-03 |
| Normal-vs-Female |
1.283920E-02 |
| Male-vs-Female |
1.569390E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.021300E-03 |
| Normal-vs-Age(41-60Yrs) |
7.104500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.091800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.302090E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.516400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.511000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.166400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.539600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.952200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.983200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
7.69900000000545E-05 |
| Normal-vs-Pheochromocytoma |
8.301100E-03 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
7.237800E-03 |
| Paraganglioma-vs-Pheochromocytoma |
2.855700E-03 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
4.045600E-02 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
6.546800E-01 |
|
|
